The Family Firm’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
10,808
+41
| +0.4% | +$3.25K | 0.25% | 70 |
|
|
2025
Q1 | $783K | Buy |
10,767
+32
| +0.3% | +$2.52K | 0.17% | 88 |
|
|
2024
Q4 | $775K | Buy |
10,735
+25
| +0.2% | +$1.9K | 0.17% | 85 |
|
|
2024
Q3 | $874K | Buy |
10,710
+20
| +0.2% | +$1.74K | 0.19% | 82 |
|
|
2024
Q2 | $1.14M | Sell |
10,690
-180
| -2% | -$17.3K | 0.25% | 70 |
|
|
2024
Q1 | $1.06M | Buy |
10,870
+30
| +0.3% | +$2.64K | 0.26% | 73 |
|
|
2023
Q4 | $849K | Buy |
10,840
+30
| +0.3% | +$2.04K | 0.22% | 80 |
|
|
2023
Q3 | $678K | Buy |
10,810
+30
| +0.3% | +$1.97K | 0.19% | 88 |
|
|
2023
Q2 | $693K | Buy |
10,780
+40
| +0.4% | +$2.25K | 0.18% | 89 |
|
|
2023
Q1 | $569K | Buy |
10,740
+40
| +0.4% | +$1.96K | 0.16% | 94 |
|
|
2022
Q4 | $450K | Buy |
10,700
+50
| +0.5% | +$2.09K | 0.13% | 106 |
|
|
2022
Q3 | $390K | Sell |
10,650
-900
| -8% | -$40.1K | 0.12% | 104 |
|
|
2022
Q2 | $492K | Buy |
11,550
+170
| +1% | +$8.09K | 0.15% | 98 |
|
|
2022
Q1 | $612K | Buy |
11,380
+20
| +0.2% | +$1.16K | 0.16% | 88 |
|
|
2021
Q4 | $817K | Hold |
11,360
| – | – | 0.21% | 77 |
|
|
2021
Q3 | $642K | Buy |
11,360
+60
| +0.5% | +$3.65K | 0.17% | 84 |
|
|
2021
Q2 | $735K | Buy |
11,300
+20
| +0.2% | +$1.26K | 0.2% | 81 |
|
|
2021
Q1 | $671K | Hold |
11,280
| – | – | 0.19% | 79 |
|
|
2020
Q4 | $618K | Buy |
11,280
+70
| +0.6% | +$2.94K | 0.18% | 81 |
|
|
2020
Q3 | $372K | Sell |
11,210
-960
| -8% | -$33.1K | 0.13% | 103 |
|
|
2020
Q2 | $394K | Buy |
12,170
+50
| +0.4% | +$1.36K | 0.15% | 97 |
|
|
2020
Q1 | $291K | Buy |
12,120
+50
| +0.4% | +$1.44K | 0.12% | 103 |
|
|
2019
Q4 | $353K | Buy |
12,070
+60
| +0.5% | +$1.59K | 0.12% | 109 |
|
|
2019
Q3 | $278K | Buy |
12,010
+70
| +0.6% | +$1.47K | 0.1% | 120 |
|
|
2019
Q2 | $224K | Buy |
11,940
+70
| +0.6% | +$1.33K | 0.08% | 135 |
|
|
2019
Q1 | $213K | Buy |
+11,870
| New | +$198K | 0.08% | 132 |
|
|
2018
Q3 | – | Sell |
-11,690
| Closed | -$202K | – | 140 |
|
|
2018
Q2 | $202K | Sell |
11,690
-440
| -4% | -$8.47K | 0.08% | 133 |
|
|
2018
Q1 | $247K | Buy |
12,130
+60
| +0.5% | +$1.19K | 0.1% | 119 |
|
|
2017
Q4 | $222K | Sell |
12,070
-190
| -2% | -$3.73K | 0.09% | 120 |
|
|
2017
Q3 | $227K | Buy |
+12,260
| New | +$199K | 0.09% | 111 |
|
Other funds holding LRCX
The Family Firm's LRCX Position: Q2 2025 in Review
The Family Firm increased its Lam Research (LRCX) stake by 0.38% in Q2 2025, buying an estimated $3.25K and bringing the position to 10,808 shares worth $1.05M. The position accounts for 0.25% of the portfolio, ranked #70.
The Family Firm first reported a position in LRCX in Q3 2017 and has held it in 30 quarters since. The position peaked at $1.14M in Q2 2024. 1,879 funds tracked by Wall St. Rank hold LRCX as of Q2 2025.
- The Family Firm held 10,808 shares of Lam Research worth $1.05M as of Q2 2025.
- The Family Firm bought 41 Lam Research shares in Q2 2025, an estimated $3.25K.
- Lam Research made up 0.25% of The Family Firm's portfolio in Q2 2025, its #70 holding.
- The Family Firm first reported a position in Lam Research in Q3 2017 and has held it in 30 quarters since.
- The Family Firm's Lam Research position peaked at $1.14M in Q2 2024.
- 1,879 funds tracked by Wall St. Rank held Lam Research as of Q2 2025.
Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.